GloPID-R 2021 Highlights and Season’s Greetings
As 2021 draws to a close, we would like to thank all our members, observers and partners for their participation and support during what has been another very active year for GloPID-R. The global community of funders has participated in an unprecedented response to the COVID-19 pandemic, and our efforts will continue in 2022.
Here are some of our activities and accomplishments over the past year.
With best wishes for a happy and healthy holiday season.
Charu Kaushic, GloPID-R Chair
A year of growth
32 members & 5 observers
In 2021, we welcomed 3 new members:
We have 2 new observers, and we are now observers of:
- ESSENCE on Health Research Initiative (WHO/TDR)
- GOARN (Global Outbreak Alert and Response Network)
The challenges facing funders
The need for coordination among funders of research is greater than ever in the face of the ongoing global health crisis. In 2021, GloPID-R worked with members and partners to identify and address the most urgent research priorities. These are the initiatives we undertook:
- We organized the Long COVID Joint Research Forum with our partners ISARIC and the Long Covid Support Group.
- Following this online forum, The Lancet Infectious Diseases published a letter authored by the GloPID-R Long COVID Forum Working Group and ISARIC.
- The Long Covid Forum Group published Research Priorities for Long COVID in BMC Medicine.
Research Project Tracker
- Developed by UKCDR and GloPID-R, the COVID-19 Research Project Tracker includes over 13,000 funded projects across 160 countries as of November 2021. We are exploring ways to expand and adapt this live database in 2022.
- In a blog post, Alice Norton, Head of the GloPID-R Scientific Secretariat, described the value of the Project Tracker and associated Living Mapping Review for funders and researchers.
COVID-19 research in LMICs
- Thousands of researchers and funders attended our online event, COVID-19 research in low- and middle-income countries, organized with partners UKCDR and COVID-19 Clinical Research Coalition.
- The GloPID-R & UKCDR COVID CIRCLE Lessons for Funders report about funding and undertaking research during the first year of the COVID-19 pandemic explores lessons learned especially in LMICs.
- A virtual dialogue, “What have we learned from funding COVID-19 research across the globe?” was co-hosted by UKCDR and GloPID-R to coincide with the release of this report.
- Marie Staunton (UKCDR) and Charu Kaushic (GloPID-R) reflect on lessons learned in “Getting COVID-19 research to the right places”.
Scientific Advisory Group (SAG) Report
Recommendations and guidance for funders
- Using a highly innovative scenario-planning methodology, the GloPID-R Scientific Advisory Group outlined research priorities through 2023 in its report Recommendations & Considerations for GloPID-R.
- Based on the SAG’s findings, the GloPID-R Co-Chairs Recommendations provided succinct guidance from our leadership for our members.
New initiatives with our members
- With our one-on-one meetings and the recently launched Member Focus and News & Events Round Up we are stepping up communications with our members.
- GloPID-R news is being amplified via social media, especially Twitter.
- The revamped GloPID-R website will be launched early in the new year.
New directions in 2022
Plans and projects in the pipeline
GloPID-R is hard at work preparing initiatives to expand in new directions:
- Exploring ways to implement the regional hub strategy with a pilot project underway in Asia Pacific.
- Continuing to work with GloPID-R members to establish similar pilot projects for regional hubs in Africa and Latin America.
- Reforming the Clinical Trials Network (CTN ) working group and establishing a globally-representative CTN & Funders working group to align regional and global approaches.
- Expanding the Research Project Tracker as a broader tool for research funders, covering a wider range of diseases with epidemic and pandemic potential.
- Developing a joint funding call for research preparedness.
- Advancing coordination and cooperation with WHO.
- Creating a joint ‘One Health’ working group with OIE/STAR-IDAZ.
- Further expanding our membership.